BCR and B-cell chronic lymphocytic leukemia: Taken together with our data for the main patient cohort, our findings further suggest that not only does the BCR response involve a wider signaling network than previously appreciated, but that this response can be reprogrammed by treating CLL cells with agents such as IL4.